Concepedia

Dasheng Wang

DW

Statistics

Publications

2

Citations

122

H-Index

2

Active since

2008

Affiliations

The Ohio State University(Current)

American Association of Colleges of Pharmacy

Dasheng Wang is an author at The Ohio State University specializing in apoptosis in cancer, molecular oncology, and oncology.

Publications per year

2008–2008

2

Publications

2

Sensitizing estrogen receptor–negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor

Shu‐Chuan Weng, Yoko Kashida, Samuel K. Kulp et al. · Molecular Cancer Therapeutics · 2008 · 64 citations

, , +17

Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors

Yu-Chieh Wang, Samuel K. Kulp, Dasheng Wang et al. · Cancer Research · 2008 · 58 citations · Full text

, , +17

1–2 of 2